Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications
Open Access
- 1 April 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 20 (4), 912-921
- https://doi.org/10.1681/asn.2008070802
Abstract
Although management of warfarin is challenging for patients with chronic kidney disease (CKD), no prospective studies have compared response to warfarin among patients with minimal, moderate, and severe CKD. This secondary analysis of a prospective cohort of 578 patients evaluated the influence of kidney function on warfarin dosage, anticoagulation control, and risk for hemorrhagic complications. We adjusted all multivariable regression and proportional hazard analyses for clinical and genetic factors. Patients with severe CKD (estimated GFR 4; P = 0.052), compared with patients with no, mild, or moderate CKD. Patients with severe CKD had a risk for major hemorrhage more than double that of patients with lesser degrees of renal dysfunction (hazard ratio 2.4, 95% confidence interval 1.1 to 5.3). In conclusion, patients with reduced kidney function require lower dosages of warfarin, have poorer control of anticoagulation, and are at a higher risk for major hemorrhage. These observations suggest that warfarin may need to be initiated at a lower dosage and monitored more closely in patients with moderate or severe CKD compared with the general population. Diminished renal function may have implications for a larger proportion of warfarin users than previously estimated.Keywords
This publication has 39 references indexed in Scilit:
- Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–AmericansPharmacogenomics, 2008
- The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillationThrombosis Research, 2007
- Anticoagulation for Chronic Atrial Fibrillation in Hemodialysis Patients: Which Fruit From the Decision Tree?American Journal of Kidney Diseases, 2007
- Influence of CYP2C9 and VKORC1 1173C/T Genotype on the Risk of Hemorrhagic Complications in African-American and European-American Patients on WarfarinClinical Pharmacology & Therapeutics, 2007
- Influence of CYP2C9 genotype on warfarin dose among African–Americans and European–AmericansPersonalized Medicine, 2007
- Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapyBlood Cells, Molecules, and Diseases, 2006
- Association of warfarin dose with genes involved in its action and metabolismHuman Genetics, 2006
- Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?International Journal of Cardiology, 2003
- Unidimensional Scale for DementiaDementia and Geriatric Cognitive Disorders, 2001
- Vitamin K1 (Phylloquinone) Content of Foods: A Provisional TableJournal of Food Composition and Analysis, 1993